Adaptive生物技术 ADPT 深 沪
交易中 03-27 10:29:38 美东时间
13.415
-0.545
-3.90%
华盛通- 最 高16.95
- 今 开13.84
- 成交量 15.54万股
- 最 低 12.00
- 昨 收 13.96
- 总市值 190.49万
- 52周最高 20.76
- 市盈率 静 --
- 换手率 109.46%
- 52周最低 6.7057
- 委 比 4.11%
- 总股本 0.00亿
- 历史最高 71.25
- 量 比 0
- 振 幅 35.46%
- 历史最低 1.10
- 每 手 1
- 风险率
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Adaptive Biotechnologies shares are trading lower. The company reported Q4 financial results.
Adaptive Biotechnologies shares are trading lower. The company reported Q4 fina...
02-07 02:50
Adaptive Biotechnologies Q4 Earnings Assessment
The Q4 earnings report for Adaptive Biotechnologies (NASDAQ:ADPT) was released ...
02-06 05:08
Earnings Scheduled For February 5, 2026
Companies Reporting Before The Bell • WEC Energy Group (NYSE:WEC) is estimated ...
02-05 19:11
Pfizer Faces Another Quiet Year As Patent Losses Cloud 2026 Outlook: Analyst
Pfizer to provide full-year 2026 financial guidance on Tuesday. BofA analyst expects flat growth, reiterates Neutral rating.
2025-12-16 01:31
Vivakor Announces Special Dividend
Vivakor announced a special dividend of Adapti shares, reflecting its investment in the tech firm and strategic partnerships.
2025-05-30 12:30
Adaptive Biotechnologies Highlights New Data at 2025 ASCO Annual Meeting and EHA 2025 Congress Demonstrating How clonoSEQ® MRD Assessment is Optimizing Patient Care and Drug Development in Lymphoid Cancers
Adaptive Biotechnologies’ clonoSEQ test for MRD assessment will feature in 30 presentations at ASCO and EHA, including 14 oral presentations, highlighting its clinical impact across multiple blood cancers. The data demonstrate MRD’s transformative role in guiding therapy and improving outcomes in diseases like multiple myeloma and chronic lymphocytic leukemia.
2025-05-30 11:30
Adaptive Biotechnologies to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference
Adaptive Biotechnologies will participate in the Goldman Sachs 46th Global Healthcare Conference, with management scheduled for a fireside chat on June 11. The event aims to showcase their immune medicine platform, which translates adaptive immune system genetics into clinical products for disease diagnosis and treatment.
2025-05-28 20:05
Jabil Posts Upbeat Earnings, Joins Micron Technology, Southwest Airlines And Other Big Stocks Moving Higher On Thursday
U.S. stocks were higher, with the Dow Jones index gaining around 250 points on ...
2024-09-27 00:34
12 Health Care Stocks Moving In Thursday's Intraday Session
Gainers Pasithea Therapeutics (NASDAQ:KTTA) stock moved upwards by 66.4% to $6...
2024-09-27 00:31
Crude Oil Down Over 2%; US Initial Jobless Claims Fall
U.S. stocks traded higher midway through trading, with the Dow Jones index gain...
2024-09-27 00:01
